Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to mic values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria;Dişa atim pompa inhibitörü 1-(1-naphthylmethyl)- piperazine'in siprofloksasine dirençli gram-negatif bakterilerin siprofloksasin mik deǧerlerine etkisi

Mikrobiyoloji Bulteni

Volumn 43, Issue 3, 2009, Pages 457-461

  Çoban, Ahmet Yilmaz ^a   Bayram, Zeynep ^a   Sezgln, Fikriye Milletl ^a   Durupinar, Belma ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

1(1 naphthylmethyl) piperazine; Ciprofloxacin; Efflux pump inhibitor; Escherichia coli; Klebsiella pneumoniae; Pseudomonas aeruginosa; Resistance

Indexed keywords

1 (1 NAPHTHYLMETHYL)PIPERAZINE; 1-(1-NAPHTHYLMETHYL)PIPERAZINE; ANTIINFECTIVE AGENT; CARRIER PROTEIN; CIPROFLOXACIN; PIPERAZINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; DRUG INTERACTION; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG INTERACTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; PSEUDOMONAS AERUGINOSA;

EID: 69249100968     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 2001; 12: 215-23.
2. Li XZ, Nikaido H. Efflux mediated drug resistance in bacteria. Drugs 2004; 64:159-204.
3. Bal Ç. Toplum kökenli enfeksiyonlarda gram-negatlf çomak direnci. Ankern Derg 2006; 20: 278-81.
4. Bohnert JA, Kern WV. Selected arylpiperazines are capable of reversing multidrug resistance in Eschen coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 2005; 49: 849-52.
5. Kern WV, Steinke P, Schumacher A Schuster S, von Baum H, Bohnert JA. Effect of 1-(1-naphthylmethyl)perazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates Escherichia coli. J Antimicrob Chemother 2006; 57: 339-43.
6. th Informational Supplement Ml00-ST8, 2008. CLSI, Wayne, Pa.
7. Schumacher A, Steinke P, Bohnert JA Akova M, Jonas D, Kern WV. Effect of 1 -(1 -naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli, j Antimicrob Chemother 2006; 57: 344-48.
8. Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa; novel agents for combination therapy. Antimicrobial Agents Chemother 2001; 45:105-16.
9. Coban AY, Ekinci B, Durupinar B. A multidrug efflux pump inhibitor reduces fluoroquinolones resistance in Pseudomonas aeruginosa isolates. Chemotherapy 2004; 50: 22-6.